Premium
Olema Pharmaceuticals Inc (OLMA)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 10 386 776 | 11,89% | US$ 110,93M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 8 020 576 | 9,18% | US$ 85,66M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | Institution | 7 473 238 | 8,56% | US$ 79,81M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 7 108 488 | 8,14% | US$ 75,92M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 6 294 992 | 7,21% | US$ 67,23M | 2024-12-31 |
| BlackRock, Inc. | Institution | 5 652 135 | 6,47% | US$ 60,36M | 2026-03-31 |
| BVF Partners L.P. | Institution | 5 295 893 | 6,06% | US$ 56,56M | 2026-03-31 |
| Artal Group S.A. | Institution | 4 461 949 | 5,11% | US$ 47,65M | 2026-04-23 |
| State Street Global Advisors, Inc. | Institution | 3 937 831 | 4,51% | US$ 42,06M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 3 900 000 | 4,46% | US$ 41,65M | 2026-03-31 |
| Invus Public Equities, L.P. | Institution | 3 898 500 | 4,46% | US$ 41,64M | 2026-04-23 |
| Logos Global Management, L.P. | Institution | 3 208 875 | 3,67% | US$ 34,27M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3 083 517 | 3,53% | US$ 32,93M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 2 655 977 | 3,04% | US$ 28,37M | 2025-06-11 |
| RA Capital Management, L.P. | Institution | 2 600 000 | 2,98% | US$ 27,77M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 2 003 966 | 2,29% | US$ 21,40M | 2025-06-11 |
| Jennison Associates LLC | Institution | 1 822 123 | 2,09% | US$ 19,46M | 2026-03-31 |
| Logos Global Master Fund, LP | Institution | 1 800 000 | 2,06% | US$ 19,22M | 2025-03-18 |
| Polar Capital Holdings Plc | Institution | 1 602 970 | 1,84% | US$ 17,12M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 544 417 | 1,77% | US$ 16,49M | 2026-03-31 |
| Defilade Capital Management, L.P. | Institution | 1 504 536 | 1,72% | US$ 16,07M | 2026-03-31 |
| Woodline Partners LP | Institution | 1 482 030 | 1,70% | US$ 15,83M | 2026-03-31 |
| Lightspeed Ventures, LLC | Institution | 1 355 299 | 1,55% | US$ 14,47M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 1 217 303 | 1,39% | US$ 13,00M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1 182 836 | 1,35% | US$ 12,63M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 1 169 421 | 1,34% | US$ 12,49M | 2026-03-31 |
| Morgan Stanley | Institution | 1 083 601 | 1,24% | US$ 11,57M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1 082 434 | 1,24% | US$ 11,56M | 2026-03-31 |
| Duquesne Family Office LLC | Institution | 986 827 | 1,13% | US$ 10,54M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 905 332 | 1,04% | US$ 9,67M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 859 027 | 0,98% | US$ 9,17M | 2026-03-31 |
| Kingdon Capital Management, L.L.C. | Institution | 855 000 | 0,98% | US$ 9,13M | 2026-03-31 |
| Dr. Cyrus Harmon | Initiés | 844 798 | 0,97% | US$ 9,02M | 2026-04-23 |
| First Turn Management, LLC | Institution | 768 662 | 0,88% | US$ 8,21M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 759 513 | 0,87% | US$ 8,11M | 2026-03-31 |
| Squarepoint OPS LLC | Institution | 738 552 | 0,85% | US$ 7,89M | 2026-03-31 |
| Logos Opportunities Fund II LP | Institution | 708 114 | 0,81% | US$ 7,56M | 2025-03-18 |
| Logos Opportunities Fund IV LP | Institution | 700 761 | 0,80% | US$ 7,48M | 2025-03-18 |
| Dr. David Myles | Initiés | 700 438 | 0,80% | US$ 7,48M | 2026-01-14 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
